Tag: pharmaceutical and biotech companies
April 30, 2018
Key Stock Catalysts in the FDA Drug Application Process
Pharmaceutical and biotech companies in the US must follow a standard process to advance a new drug candidate through nonclinical...
February 20, 2018
3D Signatures Inc. Announces Positive Topline Results of Development Trial Assessing its Telo-HL™ Test for Hodgkin’s Lymphoma
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS") is pleased to announce that a preliminary third-party analysis of...
October 10, 2017
3D Signatures Announces Completion of Stage 3 of Hodgkin’s Lymphoma Test Validation Program
3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the “Company” or “3DS”), is pleased to announce that, on September 30, 2017, the... June 19, 2017
MedReleaf Obtains Good Manufacturing Practices Certification
MedReleaf announced it became the first medical cannabis producer to receive an International Council on Harmonization certification for Good Manufacturing... February 16, 2017
Cancer Genetics' Hereditary Breast & Ovarian Cancer Panel Selected by Global Biopharma to Power 1,000+ Patient Clinical Study
Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “The Company”), a leader in precision diagnostics for oncology, announced today that its hereditary...
February 3, 2017
An Analyst’s Take on Drug Pricing and Catalysts in the Biotech Industry
In the first of a two-part series, analyst Hartaj Singh talks about the biotech industry in 2016 and 2017, drug...
December 29, 2016